Membership by application

Work through your hardest regulatory calls with people who have made them.

A private mastermind for life science regulatory affairs.

Regulatory Society brings senior regulatory professionals in pharmaceuticals, biotechnology and medical devices into small, confidential peer groups. Bring the decision in front of you. Leave with the judgment of people who have stood where you are standing.

Founding membership is open now. Every application is read by a person.

Why a mastermind

Regulatory is a lonely seat.

The more senior you become, the fewer people inside your company can test your thinking. The Society puts you in a room with the few who can.

You are the final word.

In most companies nobody else can check your reading of a guidance, or your call on a submission strategy. You decide, and the business follows.

The stakes do not wait.

The wrong pathway costs quarters, not days, and the decision is usually due before the evidence is complete.

The best answers are unwritten.

What works in practice lives in the experience of people who have been through it, more than in any guidance document.

How it works

A small group. A real problem. Honest counsel.

A mastermind is a simple idea done carefully: put a few capable peers in a room, put one live problem on the table, and let experience do the work.

  1. Apply

    Tell us your role, your product area and what you are working on. Every application is reviewed, so each group is made of genuine peers.

  2. Join your group

    You are placed in a small group matched on seniority and product type, so the conversation starts at your level.

  3. Take the hot seat

    Members bring a live problem to each session. The group questions it, pressure-tests it and shares what they have seen work.

  4. Stay connected

    A private member space keeps the conversation going between sessions, for the question that cannot wait.

What gets worked through

The calls that do not fit in a guidance document.

Groups form around three industries, because a device question and a biologics question need different rooms. These are the kinds of decisions members bring.

Industry 01

Pharmaceuticals

  • FDA meeting strategy
  • NDA and BLA planning
  • CMC changes
  • Labeling negotiations
  • Advertising and promotion review
  • Lifecycle management

Industry 02

Biotechnology

  • IND readiness
  • Expedited pathways
  • Cell and gene therapy CMC
  • The first regulatory hire
  • Partner and investor diligence
  • Global filing sequence

Industry 03

Medical devices

  • 510(k), De Novo or PMA
  • EU MDR transition
  • QMSR readiness
  • Software and AI-enabled devices
  • Notified body relationships
  • Post-market surveillance

Across every group

The leadership questions.

  • Building a regulatory team
  • Inspection readiness
  • Working with the C-suite and the board
  • AI in regulatory work
  • Your own next move

House rules

A room is only as good as its rules.

What is said in the room stays in the room.

Members share experience and judgment, never their employer's confidential information. Candour depends on both halves of that sentence.

Peers, not vendors.

Nobody is here to sell to you. Membership is for practising regulatory professionals.

Specifics over theory.

Bring the real problem and you get a real answer. General questions get general advice.

Give as much as you take.

The value of your seat is what you bring to everyone else's hot seat.

Apply

Request your seat.

Membership is by application so that every group is a group of peers. Tell us a little about your work. If the Society is a fit, you will hear from us with next steps.

  • For regulatory affairs professionals in pharmaceuticals, biotechnology and medical devices.
  • Applying takes about three minutes and commits you to nothing.
  • Your details are used only to review your application and reply to you.

By applying you agree to our privacy policy. No newsletters, no sharing your details.

Part of the Regulatory ecosystem Regulatory Events Regulatory Jobs Regulatory Leadership Regulatory News